Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 2551 AL 2565

Cholinesterase inhibitors and memantine for the treatment of Alzheimer and non-Alzheimer dementias

Balázs N, Bereczki D, Kovács T.

Ideggyogy Sz. 2021 Nov 30;74(11-12):379-387. doi: 10.18071/isz.74.0379.

Alzheimer's Disease THErapy With NEuroaid (ATHENE): A Randomized Double-Blind Delayed-Start Trial

Chen CLH, Lu Q, Moorakonda RB, Kandiah N, Tan BY, Villaraza SG, Cano J, Venketasubramanian N.

J Am Med Dir Assoc. 2022 Mar;23(3):379-386.e3. doi: 10.1016/j.jamda.2021.10.018. Epub 2021 Nov 29.

Opportunities for Drug Repurposing of Serotonin Reuptake Inhibitors: Potential Uses in Inflammation, Infection, Cancer, Neuroprotection, and Alzheimer's Disease Prevention

Nykamp MJ, Zorumski CF, Reiersen AM, Nicol GE, Cirrito J, Lenze EJ.

Pharmacopsychiatry. 2022 Jan;55(1):24-29. doi: 10.1055/a-1686-9620. Epub 2021 Dec 7.

Multi-Target Directed Ligands (MTDLs): Promising Coumarin Hybrids for Alzheimer's Disease

Bhatia R, Chakrabarti SS, Kaur U, Parashar G, Banerjee A, Rawal RK.

Curr Alzheimer Res. 2021;18(10):802-830. doi: 10.2174/1567205018666211208140551.

Pyroglutamate Aβ cascade as drug target in Alzheimer's disease

Bayer TA.

Mol Psychiatry. 2022 Apr;27(4):1880-1885. doi: 10.1038/s41380-021-01409-2. Epub 2021 Dec 8.

Applied machine learning in Alzheimer's disease research: omics, imaging, and clinical data

Li Z, Jiang X, Wang Y, Kim Y.

Emerg Top Life Sci. 2021 Dec 21;5(6):765-777. doi: 10.1042/ETLS20210249.

What have we learned from past failures of investigational drugs for Alzheimer's disease?

Imbimbo BP, Watling M.

Expert Opin Investig Drugs. 2021 Dec;30(12):1175-1182. doi: 10.1080/13543784.2021.2017881. Epub 2021 Dec 20.

Alzheimer's disease and sleep disorders: Insights into the possible disease connections and the potential therapeutic targets

Marde VS, Atkare UA, Gawali SV, Tiwari PL, Badole SP, Wankhede NL, Taksande BG, Upaganlawar AB, Umekar MJ, Kale MB.

Asian J Psychiatr. 2022 Feb;68:102961. doi: 10.1016/j.ajp.2021.102961. Epub 2021 Dec 2.

The potential pharmacological mechanisms of β-hydroxybutyrate for improving cognitive functions

Wang JH, Guo L, Wang S, Yu NW, Guo FQ.

Curr Opin Pharmacol. 2022 Feb;62:15-22. doi: 10.1016/j.coph.2021.10.005. Epub 2021 Dec 7.

Targeting tau only extracellularly is likely to be less efficacious than targeting it both intra- and extracellularly

Congdon EE, Jiang Y, Sigurdsson EM.

Semin Cell Dev Biol. 2022 Jun;126:125-137. doi: 10.1016/j.semcdb.2021.12.002. Epub 2021 Dec 9.

Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Nexus of Cholinergic and Nerve Growth Factor Dysfunction

Moss DE, Perez RG.

Curr Alzheimer Res. 2021;18(13):1010-1022. doi: 10.2174/1567205018666211215150547.

Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia

Mühlbauer V, Möhler R, Dichter MN, Zuidema SU, Köpke S, Luijendijk HJ.

Cochrane Database Syst Rev. 2021 Dec 17;12(12):CD013304. doi: 10.1002/14651858.CD013304.pub2.

Etiology and management of Alzheimer's disease: Potential role of gut microbiota modulation with probiotics supplementation

Lekchand Dasriya V, Samtiya M, Dhewa T, Puniya M, Kumar S, Ranveer S, Chaudhary V, Vij S, Behare P, Singh N, Aluko RE, Puniya AK.

J Food Biochem. 2022 Jan;46(1):e14043. doi: 10.1111/jfbc.14043. Epub 2021 Dec 19.

The role of fatty acid amide hydrolase enzyme inhibitors in Alzheimer's disease

Jain S, Bisht A, Verma K, Negi S, Paliwal S, Sharma S.

Cell Biochem Funct. 2022 Mar;40(2):106-117. doi: 10.1002/cbf.3680. Epub 2021 Dec 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias